Steris Plc’s recent filing unveils that its Sr. VP and GM, Life Sciences Madsen Julia unloaded Company’s shares for reported $1.31 million on Nov 21 ’25. In the deal valued at $262.00 per share,5,008 shares were sold. As a result of this transaction, Madsen Julia now holds 10,710 shares worth roughly $2.72 million.
Then, Madsen Julia bought 5,008 shares, generating $1,312,096 in total proceeds.
Before that, Tamaro Renato sold 5,036 shares. Steris Plc shares valued at $1,297,040 were divested by the V.P. & Corporate Treasurer at a price of $257.55 per share. As a result of the transaction, Tamaro Renato now holds 5,695 shares, worth roughly $1.45 million.
Morgan Stanley upgraded its Steris Plc [STE] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late May with a ‘”a Hold”‘ rating. Piper Sandler also remained covering STE and has increased its forecast on October 24, 2024 with a “an Overweight” recommendation from previously “Neutral” rating.
Price Performance Review of STE
On Monday, Steris Plc [NYSE:STE] saw its stock jump 0.91% to $254.07. Over the last five days, the stock has lost -2.81%. Steris Plc shares have risen nearly 21.21% since the year began. Nevertheless, the stocks have risen 23.60% over the past one year. While a 52-week high of $268.60 was reached on 11/25/25, a 52-week low of $200.98 was recorded on 01/03/25.
Levels Of Support And Resistance For STE Stock
The 24-hour chart illustrates a support level at 252.08, which if violated will result in even more drops to 250.09. On the upside, there is a resistance level at 255.41. A further resistance level may holdings at 256.75.
How much short interest is there in Steris Plc?
A steep rise in short interest was recorded in Steris Plc stocks on 2025-11-28, growing by 0.21 million shares to a total of 1.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 0.96 million shares. There was a rise of 18.18%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 30, 2023 when Morgan Stanley began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $206 price target.
